Spanish drugmaker Grifols said on Thursday it expects its revenue, core earnings and free cash flow to grow significantly in ...

Grifols revenue and EBITDA growth, improved leverage ratio, and significant liquidity highlight its resilience and potential ...

Activist hedge fund Gotham lambasted healthcare firm Grifols last year. Some of its key criticisms were vindicated. And its ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Grifols said it expects positive free cash flow to rise to €1.2-billion in 2029 and to €350 million-€400-million in 2025 ...

More than two dozen people rallied on Monday against a for-profit clinic in Whitby that pays people for plasma ...

The company said, “Building on the solid performance of 2024, Grifols (GRFS) forecasts continued success in 2025 with anticipated revenue ...

Amid a dearth of new deals, fee-starved investment bankers and private credit lenders are salivating over the prospect of ...

Building on the solid performance of 2024, Grifols (GRFS) forecasts continued success in 2025 with anticipated revenue growth and EBITDA ...

Walgreens has also been the past subject of buyout talks that failed to materialize. The iconic American retail pharmacy has ...